Oren G. Livnat is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the specialty pharmaceutical industry. Mr. Livnat conducted more than twelve years of research on both the sell-side and the buy-side. Prior to joining H.C. Wainwright, Mr. Livnat worked as a Senior Analyst covering specialty and generic pharma at Iguana Healthcare Partners, a dedicated healthcare long/short hedge fund. Mr. Livnat began his career as an Associate at Natixis Bleichroeder and successively worked as a Senior Analyst at JMP Securities covering both commercial and development-stage companies.
Prior to that, Mr. Livnat also worked at Jefferies LLC covering Spec Pharma. Mr. Livnat’s educational background includes a B.A. in Economics from Wesleyan University. Mr. Livnat is also a Chartered Financial Analyst (CFA) charterholder.
